SAMPSON, PETER BRENT,LIU, YONG,LI, SZE-WAN,FORREST, BRYAN T.,PAULS, HEINZ W.,EDWARDS, LOUISE G.,FEHER, MIKLOS,PATEL, NARENDRA KUMAR B.,LAUFER, RADOSLAW,PAN, GUOHUA
申请号：
SG2012065090
公开号：
SG183875A1
申请日:
2011.04.06
申请国别(地区):
SG
年份:
2012
代理人:
摘要：
The invention is directed to a compound represented by the following structural formula pharmaceutically acceptable salts thereof: (I). Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
